Free Cholesterol In Hdl
Introduction
Free cholesterol in High-Density Lipoprotein (HDL) refers to the unesterified form of cholesterol carried within HDL particles. HDL is widely recognized for its crucial role in reverse cholesterol transport, a biological process where excess cholesterol is removed from peripheral cells and transported back to the liver. This mechanism is essential for maintaining cellular cholesterol balance and preventing the accumulation of cholesterol in tissues, including the walls of arteries.
Biological Basis
HDL particles are primarily synthesized in the liver and intestines. As nascent HDL circulates, it actively acquires free cholesterol from cells through various transporters, notably the ATP-binding cassette transporter A1 (ABCA1). [1] Once incorporated into the HDL particle, free cholesterol is rapidly converted into cholesterol esters by the enzyme lecithin-cholesterol acyltransferase (LCAT). These more hydrophobic cholesterol esters move into the core of the HDL particle, allowing the particle to mature and continue accepting free cholesterol from cells. Genetic variations in several genes involved in lipid metabolism have been shown to influence HDL cholesterol levels. These include genes such as ABCA1, the APOA1-APOC3-APOA4-APOA5 gene cluster, CETP, LIPC, LIPG, and LPL. [2] Specific single nucleotide polymorphisms (SNPs), such as rs4846914 in GALNT2, have been associated with altered HDL cholesterol concentrations. [2] Other SNPs, like rs17145738 near TBL2 and MLXIPL and rs17321515 near TRIB1, have also demonstrated associations with HDL cholesterol levels. [2] Collectively, common genetic variants at these and other loci are estimated to explain a significant fraction of the inter-individual variability in HDL cholesterol concentrations within the population. [2]
Clinical Relevance
Healthy levels of HDL cholesterol are generally associated with a reduced risk of cardiovascular diseases (CVD). [1] Beyond the total concentration, the functionality of HDL, including its capacity to accept and transport free cholesterol, is increasingly recognized as a key factor. Dysfunctional HDL, even if present in high amounts, may not confer the same protective benefits. Genetic predispositions significantly influence an individual's lipid profile and, consequently, their susceptibility to dyslipidemia and coronary artery disease (CAD). [1] Research has identified numerous genetic loci influencing HDL cholesterol levels, which are in turn linked to CAD risk. [3] Understanding these genetic influences can aid in assessing an individual's risk and potentially guiding targeted preventive or therapeutic strategies.
Social Importance
Cardiovascular diseases, including CAD, represent a leading cause of morbidity and mortality globally. Given the strong association between lipid profiles and CVD risk, understanding the genetic and biological factors that influence free cholesterol in HDL is of substantial social importance. This knowledge contributes to public health strategies aimed at preventing CVD, ranging from identifying individuals at higher genetic risk to developing more personalized approaches for lifestyle interventions and pharmacological treatments. Research into these genetic variations helps to unravel the complex interplay between genes, environmental factors, and health outcomes, thereby informing precision medicine efforts.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs72786786 | HERPUD1 - CETP | depressive symptom measurement, non-high density lipoprotein cholesterol measurement HDL cholesterol change measurement, physical activity total cholesterol measurement, high density lipoprotein cholesterol measurement free cholesterol measurement, high density lipoprotein cholesterol measurement phospholipid amount, high density lipoprotein cholesterol measurement |
| rs1077835 | ALDH1A2, LIPC | triglyceride measurement high density lipoprotein cholesterol measurement level of phosphatidylcholine level of phosphatidylethanolamine total cholesterol measurement |
| rs1601935 | ALDH1A2 | total cholesterol measurement triglyceride measurement high density lipoprotein cholesterol measurement triglyceride measurement, low density lipoprotein cholesterol measurement lipid measurement, high density lipoprotein cholesterol measurement |
| rs325 rs144503444 |
LPL | high density lipoprotein cholesterol measurement level of phosphatidylcholine sphingomyelin measurement diacylglycerol 36:2 measurement diacylglycerol 36:3 measurement |
| rs6073958 | PLTP - PCIF1 | triglyceride measurement HDL particle size high density lipoprotein cholesterol measurement alcohol consumption quality, high density lipoprotein cholesterol measurement triglyceride measurement, alcohol drinking |
| rs102275 | TMEM258 | coronary artery calcification Crohn's disease fatty acid amount high density lipoprotein cholesterol measurement, metabolic syndrome phospholipid amount |
| rs77960347 rs78349695 |
LIPG | apolipoprotein A 1 measurement level of phosphatidylinositol total cholesterol measurement high density lipoprotein cholesterol measurement low density lipoprotein cholesterol measurement |
| rs7241918 | LIPG - SMUG1P1 | high density lipoprotein cholesterol measurement total cholesterol measurement C-reactive protein measurement cholesteryl ester measurement, intermediate density lipoprotein measurement lipid measurement, intermediate density lipoprotein measurement |
| rs10162642 | ALDH1A2 | level of vitelline membrane outer layer protein 1 in blood matrix-remodeling-associated protein 8 measurement high density lipoprotein cholesterol measurement total cholesterol measurement HDL particle size |
| rs116843064 | ANGPTL4 | triglyceride measurement high density lipoprotein cholesterol measurement coronary artery disease phospholipid amount, high density lipoprotein cholesterol measurement alcohol consumption quality, high density lipoprotein cholesterol measurement |
References
[1] Aulchenko, Y. S., et al. "Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts." Nat Genet, vol. 41, no. 1, 2009, pp. 47-55.
[2] Kathiresan, S., et al. "Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans." Nat Genet, vol. 40, no. 2, 2008, pp. 189-197.
[3] Willer, C. J., et al. "Newly identified loci that influence lipid concentrations and risk of coronary artery disease." Nat Genet, vol. 40, no. 2, 2008, pp. 161-169.